01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
The National Labor Relations Board (NLRB) issued two decisions on December 17, 2019, that reversed p...
Read More >
Medical marijuana has finally arrived. Over 53,000 Ohio residents have applied for and received medi...
Read More >
On January 21, 2020, the Internal Revenue Service (IRS) released guidance for tax-exempt organizatio...
Read More >
On January 9, 2020, the Iowa Court of Appeals released two opinions – Dix v. Casey’s General Store...
Read More >
The City of Dallas recently enacted a paid sick leave (PSL) ordinance requiring employers to provide...
Read More >
On September 14, the U.S. Court of Appeals for the Third Circuit addressed the perennially thorny is...
Read More >